Silvana Fiorante-rekin lankidetzan egindako argitalpenak (12)

2015

  1. Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults

    Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 104.e1-104.e5

  2. Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)

    Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 105.e1-105.e5

2014

  1. Incidence of Hepatitis C Virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004-2011: Increasing rates of HCV diagnosis but not of HCV seroconversions

    PLoS ONE, Vol. 9, Núm. 12

  2. Tuberculosis in a cohort of HIV-positive patients: Epidemiology, clinical practice and treatment outcomes

    International Journal of Tuberculosis and Lung Disease, Vol. 18, Núm. 6

2013

  1. Should we look for Strongyloides stercoralis in foreign-born HIV-infected persons?

    Journal of Immigrant and Minority Health, Vol. 15, Núm. 4, pp. 796-802

2012

  1. Características clínico-epidemiológicas de los pacientes inmigrantes con infección por el VIH: estudio de 371 casos

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 30, Núm. 8, pp. 441-451

  2. Chagas disease screening among HIV-positive Latin American immigrants: An emerging problem

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 31, Núm. 8, pp. 1991-1997

  3. Lack of the detection of XMRV or polytropic MLV-related sequences in blood cells from HIV-1-infected patients in spain

    Journal of Acquired Immune Deficiency Syndromes, Vol. 59, Núm. 2, pp. 101-104

2011

  1. Sustained profile of transmitted drug resistance mutations for more than 10 years in an HIV type 1-infected patient

    AIDS Research and Human Retroviruses, Vol. 27, Núm. 1, pp. 41-45

2010

  1. Boosted protease inhibitor monotherapy. What have we learnt after seven years of research?

    AIDS Reviews, Vol. 12, Núm. 3, pp. 127-134

  2. Detection of HIV-1 at between 20 and 49 copies per milliliter by the Cobas TaqMan HIV-1 v2.0 assay is associated with higher pretherapy viral load and less time on antiretroviral therapy

    Journal of Clinical Microbiology, Vol. 48, Núm. 5, pp. 1911-1912

2008

  1. Datos clínicos II. Experiencia clínica de tenofovir en combinaciones con inhibidores de proteasa

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. SUPPL. 8, pp. 13-18